Lung cancer immunotherapy: progress, pitfalls, and promises
A Lahiri, A Maji, PD Potdar, N Singh, P Parikh, B Bisht… - Molecular cancer, 2023 - Springer
Lung cancer is the primary cause of mortality in the United States and around the globe.
Therapeutic options for lung cancer treatment include surgery, radiation therapy …
Therapeutic options for lung cancer treatment include surgery, radiation therapy …
The potential role of N7-methylguanosine (m7G) in cancer
Y Luo, Y Yao, P Wu, X Zi, N Sun, J He - Journal of hematology & oncology, 2022 - Springer
Abstract N 7-methylguanosine (m7G), one of the most prevalent RNA modifications, has
recently attracted significant attention. The m7G modification actively participates in …
recently attracted significant attention. The m7G modification actively participates in …
circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity
Circular RNAs (circRNA) are a class of covalently closed single-stranded RNAs that have
been implicated in cancer progression. Here we identify circNDUFB2 to be downregulated …
been implicated in cancer progression. Here we identify circNDUFB2 to be downregulated …
Artificial intelligence in lung cancer diagnosis and prognosis: Current application and future perspective
Lung cancer is one of the malignant tumors with the highest incidence and mortality in the
world. The overall five-year survival rate of lung cancer is relatively lower than many leading …
world. The overall five-year survival rate of lung cancer is relatively lower than many leading …
[PDF][PDF] Integrative proteomic characterization of human lung adenocarcinoma
JY Xu, C Zhang, X Wang, L Zhai, Y Ma, Y Mao, K Qian… - Cell, 2020 - cell.com
Genomic studies of lung adenocarcinoma (LUAD) have advanced our understanding of the
disease's biology and accelerated targeted therapy. However, the proteomic characteristics …
disease's biology and accelerated targeted therapy. However, the proteomic characteristics …
Cancer progress and priorities: lung cancer
MB Schabath, ML Cote - Cancer epidemiology, biomarkers & prevention, 2019 - AACR
In the United States, lung cancer is the second most common diagnosed cancer and the
leading cause of cancer-related death. Although tobacco smoking is the major risk factor …
leading cause of cancer-related death. Although tobacco smoking is the major risk factor …
[HTML][HTML] Tumor-associated macrophages in human breast, colorectal, lung, ovarian and prostate cancers
I Larionova, G Tuguzbaeva, A Ponomaryova… - Frontiers in …, 2020 - frontiersin.org
Tumor-associated macrophages (TAMs) are major innate immune cells that constitute up to
50% of the cell mass of human tumors. TAMs are highly heterogeneous cells that originate …
50% of the cell mass of human tumors. TAMs are highly heterogeneous cells that originate …
The application of ferroptosis in diseases
Ferroptosis is a new kind of regulated cell death that is characterized by highly iron-
dependent lipid peroxidation. Ferroptosis involves various biology processes, such as iron …
dependent lipid peroxidation. Ferroptosis involves various biology processes, such as iron …
Identification of the pyroptosis‑related prognostic gene signature and the associated regulation axis in lung adenocarcinoma
W Lin, Y Chen, B Wu, Y Chen, Z Li - Cell death discovery, 2021 - nature.com
Lung adenocarcinoma (LUAD) remains the most common deadly disease and has a poor
prognosis. Pyroptosis could regulate tumour cell proliferation, invasion, and metastasis …
prognosis. Pyroptosis could regulate tumour cell proliferation, invasion, and metastasis …
miRNAs as potential game-changers in bone diseases: Future medicinal and clinical Uses
Abstract MicroRNAs (miRNAs), short, highly conserved non-coding RNA, influence gene
expression by sequential mechanisms such as mRNA breakdown or translational …
expression by sequential mechanisms such as mRNA breakdown or translational …